Food and Drug Administration has issued warning letters to 30 telehealth companies for making false or misleading claims ...
March 3 (Reuters) - The U.S. Food and Drug Administration has warned Novo Nordisk over a consumer ad for its blockbuster ...
It's rare to make it through an episode of your favorite show without seeing a commercial for a prescription drug that ...
(THE CONVERSATION) It’s a familiar experience for many Americans: You’re watching your favorite show and suddenly you’re ambushed by an ad for a drug whose name sounds like a Wi-Fi password, before a ...
FDA sends Novo Nordisk 2nd warning over GLP-1 ads for misleading claims in Ozempic promotion and risk disclosure violations.
Food and Drug Administration has told Novo Nordisk to stop running a consumer ad for its blockbuster diabetes drug Ozempic, saying the commercial makes false and misleading claims about what the ...
Direct-to-consumer drug advertising has long been opposed by the American Medical Association — and now the Trump ...
In Focus delivers deeper coverage of the political, cultural, and ideological issues shaping America. Published daily by senior writers and experts, these in-depth pieces go beyond the headlines to ...
The ethics of direct-to-consumer ads from pharmaceutical companies is being debated as the FDA looks towards possibly banning them altogether.
Food and Drug Administration has told Novo Nordisk to stop running a consumer ad for its blockbuster diabetes drug Ozempic, saying the commercial makes false and misleading claims about what ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results